Abbott ID NOW™ COVID-19 assay: do not discard the swab

Author:

MacDonald ClaytonORCID,Desruisseaux Claudine,Eckbo Eric,Li Lisa,Locher Kerstin,Wong Titus,Grant JenniferORCID,Lavergne Valery,Schaeffer David F.,Hoang Linda M.N.,Charles Marthe

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference11 articles.

1. Hsu A, Lane N. Report: understanding the impact of COVID-19 on residents of Canada's long-term care homes — ongoing challenges and policy responses2020. Article in LTCcovid.org, International Long-Term Care Policy Network, CPEC-LSE, 4 June 2020.

2. Abbot. Abbott releases ID NOW™ COVID-19 interim clinical study results from 1,003 people to provide the facts on clinical performance and to support public health. Abbot Online: Abbot Media; 2020.

3. Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCoV reverse transcriptase PCR assay for the detection of SARS-CoV-2;Moore;J Clin Microbiol,2020

4. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the rapid detection of SARS-CoV-2;Smithgall;J Clin Virol,2020

5. Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19;Stokes;medRxiv,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3